BioCentury | Apr 15, 2013
Company News

AnGes, BioLeaders, GenoLac deal

...AnGes received exclusive, worldwide rights to develop and commercialize GenoLac's and BioLeader's HPV vaccine candidate to...
...2011). AnGes MG Inc. (Tokyo:4563), Osaka, Japan BioLeaders Corp. Co. Ltd. , Daejeon, South Korea GenoLac BL Corp....
BioCentury | May 28, 2012
Company News

AnGes, Morishita deal

...vaccine targeting E7 transforming protein (human papillomavirus-16; HpV16gp1). AnGes is developing the preclinical vaccine with GenoLac BL Corp....
BioCentury | Aug 15, 2011
Finance

Highlights of weekly biotech stock moves

...to $1.74. AnGes MG Inc. (Tokyo:4563) gained ¥5,100 to ¥73,400 last week after partnering with GenoLac BL Corp....
BioCentury | Aug 15, 2011
Company News

AnGes, GenoLac BL Corp. deal

...AnGes and GenoLac partnered to co-develop an HPV vaccine targeting E7 transforming protein (human papillomavirus-16; HpV16gp1...
...transforming protein (human papillomavirus-16; HpV16gp1). Details were not disclosed. AnGes MG Inc. (Tokyo:4563), Osaka, Japan GenoLac BL Corp....
BioCentury | Aug 9, 2011
Company News

AnGes, GenoLac in HPV deal

...AnGes MG Inc. (Tokyo:4563) and GenoLac BL Corp. (Okinawa, Japan) partnered to co-develop an HPV vaccine targeting E7...
Items per page:
1 - 5 of 5
BioCentury | Apr 15, 2013
Company News

AnGes, BioLeaders, GenoLac deal

...AnGes received exclusive, worldwide rights to develop and commercialize GenoLac's and BioLeader's HPV vaccine candidate to...
...2011). AnGes MG Inc. (Tokyo:4563), Osaka, Japan BioLeaders Corp. Co. Ltd. , Daejeon, South Korea GenoLac BL Corp....
BioCentury | May 28, 2012
Company News

AnGes, Morishita deal

...vaccine targeting E7 transforming protein (human papillomavirus-16; HpV16gp1). AnGes is developing the preclinical vaccine with GenoLac BL Corp....
BioCentury | Aug 15, 2011
Finance

Highlights of weekly biotech stock moves

...to $1.74. AnGes MG Inc. (Tokyo:4563) gained ¥5,100 to ¥73,400 last week after partnering with GenoLac BL Corp....
BioCentury | Aug 15, 2011
Company News

AnGes, GenoLac BL Corp. deal

...AnGes and GenoLac partnered to co-develop an HPV vaccine targeting E7 transforming protein (human papillomavirus-16; HpV16gp1...
...transforming protein (human papillomavirus-16; HpV16gp1). Details were not disclosed. AnGes MG Inc. (Tokyo:4563), Osaka, Japan GenoLac BL Corp....
BioCentury | Aug 9, 2011
Company News

AnGes, GenoLac in HPV deal

...AnGes MG Inc. (Tokyo:4563) and GenoLac BL Corp. (Okinawa, Japan) partnered to co-develop an HPV vaccine targeting E7...
Items per page:
1 - 5 of 5